 产品搜索 |
| 产品类别 |
| 推荐产品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3- |
| 1,3-二苯基异苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧 |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮杂吲哚 |
| 4-氮杂吲哚 |
| 5-氮杂吲哚 |
| 6-氮杂吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖盐酸盐 |
| N-乙酰基-D-氨基半乳糖 |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-赖氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯 |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基异 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基 |
| 2-氯-1-甲基吡啶碘盐 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三异丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 产品展示 |
| 产品编号 |
产品名称 |
CAS No. |
含量 |
| NX90995 | ethyl 4-[4-(2-methoxy-benzylidene)-3,5-dioxo-pyrazolidin-1-yl]-benzoate | 820238-42-4 | 95% |
| NX90996 | (2-acetyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-acetic acid | 866459-09-8 | 95% |
| NX90997 | (2-ethoxycarbonyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-acetic acid | 213814-90-5 | 95% |
| NX90998 | (2-cyclopropanecarbonyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-acetic acid | 866459-17-8 | 95% |
| NX90999 | [2-(furan-3-carbonyl)-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl]-acetic acid | 866459-55-4 | 95% |
| NX91000 | (2-benzoyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-acetic acid | 866459-11-2 | 95% |
| NX91001 | ethyl (2-tert-butoxycarbonyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-acetate | 866459-02-1 | 95% |
| NX91002 | (2-butoxycarbonyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-acetic acid | 866459-05-4 | 95% |
| NX91003 | [2-(pyridine-4-carbonyl)-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl]-acetic acid | 866459-61-2 | 95% |
| NX91004 | [2-(pyrazine-2-carbonyl)-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl]-acetic acid | 866459-42-9 | 95% |
| NX91005 | 5-carboxymethyl-7-methyl-1,3,4,5-tetrahydro-pyrido[4,3-b]indole-2-carboxylic acid tert-butyl ester | 866459-72-5 | 95% |
| NX91006 | (2-benzyloxycarbonyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-acetic acid | 866459-03-2 | 95% |
| NX91007 | (2-benzoyl-8-tert-butyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-acetic acid | 866460-11-9 | 95% |
| NX91008 | (2-benzylsulfanyl-5-nitro-benzoimidazol-1-yl)-acetic acid | 877627-47-9 | 95% |
| NX91009 | tert-butyl [2-(2-methoxy-benzylsulfanyl)-benzoimidazol-1-yl]-acetate | 877623-65-9 | 95% |
| NX91010 | [2-(2-cyclohexyl-ethylsulfanyl)-benzoimidazol-1-yl]-acetic acid | 877623-45-5 | 95% |
| NX91011 | [2-(2-tert-butoxycarbonylamino-ethylsulfanyl)-benzoimidazol-1-yl]-acetic acid | 877626-81-8 | 95% |
| NX91012 | tert-butyl (2-benzylsulfanyl-5-nitro-benzoimidazol-1-yl)-acetate | 877627-48-0 | 95% |
| NX91013 | {2-[3-(cyclopropanecarbonyl-amino)-propylsulfanyl]-benzoimidazol-1-yl}-acetic acid | 877625-59-7 | 95% |
| NX91014 | (2-{3-[(furan-2-carbonyl)-amino]-propylsulfanyl}-benzoimidazol-1-yl)-acetic acid | 877625-58-6 | 95% |
| NX91015 | [2-(3-tert-butoxycarbonyl-amino-propylsulfanyl)-benzoimidazol-1-yl]-acetic acid | 877626-39-6 | 95% |
| NX91016 | tert-butyl {2-[2-(4-chloro-phenoxy)-ethylsulfanyl]-benzoimidazol-1-yl}-acetate | 877623-73-9 | 95% |
| NX91017 | tert-butyl [2-(4-methyloxycarbonyl-oxazol-2-ylmethylsulfanyl)-benzoimidazol-1-yl]-acetate | 877627-78-6 | 95% |
| NX91018 | [2-(3-benzylamino-propylsulfanyl)-benzoimidazol-1-yl]-acetic acid | 877626-71-6 | 95% |
| NX91019 | tert-butyl [2-(2-cyclohexyl-ethylsulfanyl)-benzoimidazol-1-yl]-acetate | 877623-46-6 | 95% |
| NX91020 | tert-butyl [2-(3-methoxycarbonyl-benzylsulfanyl)-benzoimidazol-1-yl]-acetate | 877624-16-3 | 95% |
| NX91021 | tert-butyl [2-(2-tert-butoxycarbonylamino-ethylsulfanyl)-benzoimidazol-1-yl]-acetate | 877626-82-9 | 95% |
| NX91022 | tert-butyl [2-(3-benzoylamino-propylsulfanyl)-benzoimidazol-1-yl]-acetate | 877626-41-0 | 95% |
| NX91023 | tert-butyl {2-[(6-bromo-3-methoxycarbonyl)-benzylsulfanyl]-benzoimidazol-1-yl}acetate | 877624-33-4 | 95% |
| NX91024 | tert-butyl {2-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethylsulfanyl]-benzoimidazol-1-yl}-acetate | 877626-87-4 | 95% |
|
|
|
|
